20th November 2021 | Pharma Updates
With innovation, Indian pharma can touch $130 bn by 2030: Industry
Sun Pharma says it eyes USD 1.5 bn from innovative products in next 3 to 4 years.
‘Indian drug companies preparing to grab opportunities in global supply of oral Covid drugs’
With the launch of new innovative Covid oral drugs, Indian companies are again expected to grab opportunities in the global supply of oral Covid drugs, according to GlobalData.
Flipkart to buy online pharmacy SastaSundar
The acquisition comes right after competitor Amazon India has entered the category last year.
AIMIL Pharma brings Ayurvedic Beauty Product
The product Ayouthveda has been made by using herbs which are also used in ayurvedic medicines.
Vaccine hesitancy big danger to our country: SII
India is sitting on over 20 mn Covid vaccines due to reluctance among people towards vaccines.
Laurus Labs buys minority stake in CAR-T cell therapy company
Laurus Labs has inked an investment agreement with Immunoadoptive Cell Therapy to buy a 26.62% stake for a cash consideration of approximately 46 cr INR.
CureVac to start trials for next-generation Covid shots
Clinical trials for its Covid vaccine are expected to start in a few months.